• Drug Discovery
  • Cancer Research UK Funded Institutes
  • Small Molecule Drug Discovery
  • Discovery Committee
• CRT's Discovery Laboratories
  • What we do
  • Our Pipeline
  • Our Senior Scientists
  • Our Scientific Advisory Board
  • Case studies
• Imaging & Diagnostics
• Drug Development
• Partnerships with Industry
  • Academic Consortia
  • Drug Discovery Alliances
  • Cancer Metabolism
  • DNA Damage Response

Our Pipeline

CRT's Discovery Laboratories scientists are collaborating with groups at leading research institutes worldwide to develop new cancer therapies.

Our in-house drug discovery programmes include the identification of small molecule inhibitors against various target classes including kinases, kinesins, methyltransferases and molecular chaperone targets, and are at various stages of development.

CRT DL’s active project portfolio is currently 15 projects, 14 of these being small molecule projects and one a biological therapeutic. The portfolio below represents a few selected projects.